Showing 481 - 500 results of 101,254 for search '(( 30 point decrease ) OR ( 5 ((((wt decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.40s Refine Results
  1. 481
  2. 482

    Selective downregulation of SR Ca<sup>2+</sup> handling proteins and decreased SR Ca<sup>2+</sup> uptake in TG mice hearts. by Mayilvahanan Shanmugam (691549)

    Published 2015
    “…For each atrial Ca<sup>2+</sup> uptake experiment, atria from four mice were pooled. n = 4 for each group. The V<sub>max</sub> of Ca<sup>2+</sup> uptake was obtained at pCa 5.5.…”
  3. 483
  4. 484
  5. 485
  6. 486
  7. 487
  8. 488
  9. 489

    Decreased plaque size in ORP8 KO BM recipients and increased plaque macrophage content after 9 weeks WTD feeding. by Erik van Kampen (649704)

    Published 2014
    “…After 9 weeks of WTD feeding following BMT, a decrease in plaque size could be measured. No difference was observed after 6 weeks of dietary challenge. …”
  10. 490
  11. 491
  12. 492
  13. 493
  14. 494
  15. 495
  16. 496

    Decreased remyelination initiation is observed in Scribble cKO mice following focal demyelination in corpus callosum. by Andrew A. Jarjour (343100)

    Published 2015
    “…In the contralateral (unlesioned) hemisphere (CL), no difference was seen in the proportion of axons in the corpus callosum that were myelinated in Scribble cKO compared to wild-type animals (A–C). Fewer remyelinated axons were observed in corpus callosum in the lesion area in Scribble cKO mice (E) relative to controls (D) as quantified in F; 0.4–0.5 μm: WT = 80.0% ± 9.8%, cKO = 41.3% ± 8.9% myelinated; 0.5–0.6 μm: WT = 79.4% ± 6.3%, cKO = 41.5% ± 9.5% myelinated; 0.6–0.7 μm: WT = 91.6% ± 3.0%, cKO = 44.3% ± 8.7% myelinated; >0.7 μm: WT = 92.7% ± 1.9%, cKO = 47.9% ± 2.5% myelinated. …”
  17. 497
  18. 498
  19. 499

    Heat inactivation curves for the WT SULT1A1 protein and the 5C2, 5F8 and D249G SULT1A1 mutants. by Ilana Berger (198531)

    Published 2011
    “…The decrease in stability of the 5F8 mutant, relative to 1E8, and the D249G mutant, relative to the WT protein, highlight the trade-off between thermostability and the acquisition of new catalytic properties (see text for details).…”
  20. 500

    Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

    Published 2013
    “…<p>Rh4 and RMS13 cells were treated for 24 hours (A) and 48 hours (B) with different concentrations of fenretinide (0.5–1–5 µM, as indicated). …”